Choreo LLC Has $355,000 Stock Holdings in Lam Research Co. (NASDAQ:LRCX)

Choreo LLC decreased its position in Lam Research Co. (NASDAQ:LRCX) by 8.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 452 shares of the semiconductor company’s stock after selling 42 shares during the period. Choreo LLC’s holdings in Lam Research were worth $355,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in LRCX. Arlington Trust Co LLC lifted its position in Lam Research by 7.7% in the 4th quarter. Arlington Trust Co LLC now owns 182 shares of the semiconductor company’s stock valued at $143,000 after acquiring an additional 13 shares in the last quarter. CNB Bank boosted its position in shares of Lam Research by 1.4% during the fourth quarter. CNB Bank now owns 1,032 shares of the semiconductor company’s stock worth $808,000 after buying an additional 14 shares during the period. TRUE Private Wealth Advisors boosted its position in shares of Lam Research by 4.1% during the fourth quarter. TRUE Private Wealth Advisors now owns 378 shares of the semiconductor company’s stock worth $296,000 after buying an additional 15 shares during the period. Asset Dedication LLC grew its holdings in shares of Lam Research by 56.7% during the third quarter. Asset Dedication LLC now owns 47 shares of the semiconductor company’s stock worth $30,000 after buying an additional 17 shares in the last quarter. Finally, Western Financial Corp CA lifted its stake in Lam Research by 1.7% in the 4th quarter. Western Financial Corp CA now owns 1,003 shares of the semiconductor company’s stock valued at $786,000 after acquiring an additional 17 shares in the last quarter. Institutional investors own 84.61% of the company’s stock.

Lam Research Stock Up 2.8 %

Shares of LRCX opened at $908.53 on Friday. The firm has a market cap of $119.11 billion, a P/E ratio of 33.41, a price-to-earnings-growth ratio of 2.74 and a beta of 1.51. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.84 and a current ratio of 2.82. Lam Research Co. has a 52 week low of $507.19 and a 52 week high of $1,007.39. The firm’s 50-day simple moving average is $941.71 and its 200 day simple moving average is $816.04.

Lam Research (NASDAQ:LRCX) last announced its earnings results on Wednesday, April 24th. The semiconductor company reported $7.79 earnings per share for the quarter, topping analysts’ consensus estimates of $7.26 by $0.53. The company had revenue of $3.79 billion for the quarter, compared to analyst estimates of $3.72 billion. Lam Research had a return on equity of 45.96% and a net margin of 25.35%. The firm’s quarterly revenue was down 2.0% compared to the same quarter last year. During the same quarter last year, the company earned $6.99 earnings per share. On average, analysts forecast that Lam Research Co. will post 29.62 earnings per share for the current year.

Lam Research Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, April 3rd. Stockholders of record on Wednesday, March 13th were given a $2.00 dividend. The ex-dividend date was Tuesday, March 12th. This represents a $8.00 dividend on an annualized basis and a dividend yield of 0.88%. Lam Research’s payout ratio is presently 29.42%.

Insider Activity at Lam Research

In other Lam Research news, EVP Patrick J. Lord sold 60 shares of Lam Research stock in a transaction dated Monday, April 29th. The shares were sold at an average price of $921.54, for a total value of $55,292.40. Following the completion of the sale, the executive vice president now owns 4,454 shares in the company, valued at approximately $4,104,539.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, SVP Seshasayee Varadarajan sold 5,500 shares of the stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $922.41, for a total transaction of $5,073,255.00. Following the sale, the senior vice president now owns 22,095 shares of the company’s stock, valued at $20,380,648.95. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Patrick J. Lord sold 60 shares of Lam Research stock in a transaction on Monday, April 29th. The shares were sold at an average price of $921.54, for a total value of $55,292.40. Following the completion of the transaction, the executive vice president now directly owns 4,454 shares of the company’s stock, valued at $4,104,539.16. The disclosure for this sale can be found here. Over the last three months, insiders have sold 7,089 shares of company stock worth $6,614,781. Corporate insiders own 0.32% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on LRCX shares. Stifel Nicolaus raised their price target on shares of Lam Research from $950.00 to $1,050.00 and gave the stock a “buy” rating in a research note on Tuesday, April 16th. JPMorgan Chase & Co. raised their target price on shares of Lam Research from $900.00 to $950.00 and gave the company an “overweight” rating in a research report on Thursday, April 25th. Susquehanna cut their price target on shares of Lam Research from $880.00 to $850.00 and set a “neutral” rating on the stock in a research report on Thursday, April 25th. Cantor Fitzgerald restated a “neutral” rating and issued a $1,100.00 price objective on shares of Lam Research in a report on Thursday, April 25th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $1,030.00 target price on shares of Lam Research in a research report on Thursday, April 25th. Seven investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $950.85.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.